moxisylyte has been researched along with Blepharoptosis in 1 studies
Moxisylyte: An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)
Blepharoptosis: Drooping of the upper lid due to deficient development or paralysis of the levator palpebrae muscle.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chitkara, DK | 1 |
| Hudson, JM | 1 |
1 other study available for moxisylyte and Blepharoptosis
| Article | Year |
|---|---|
Blepharoptosis caused by systemic thymoxamine.
Topics: Aged; Aged, 80 and over; Blepharoptosis; Female; Humans; Moxisylyte; Oculomotor Muscles | 1991 |